October 11, 2023
Mitotech CEO To Present At LSX Investival Showcase 2023
October 1, 2023
Mitotech COO To Present At Bio Investor Forum 2023
September 21, 2023
Mitotech CSO to present at Targeting Mitochondria 2023 Conference
October 13, 2022
Essex Biotechnology Secures Exclusive Rights in Mitotech’s lead candidate SkQ1 for Ophthalmology
February 24, 2022
Mitotech CSO to present at Mitochondria-Targeted Drug Development Summit
January 26, 2022
Mitotech to Host Key Opinion Leader Webinar on Visomitin®: A Potential Treatment for Dry Eye Disease
December 15, 2021
Mitotech granted Orphan Drug Designation by FDA for Visomitin® in LHON
May 6, 2021
Mitotech's focus on opthalmology discussed in Fierce Biotech publication
March 4, 2021
Mitotech CEO Natalia Perekhvatova to present at OIS Dry Eye Innovation Showcase 2021
February 26, 2021
February 1, 2021
Mitotech to present at LSX Congress 2021
January 11, 2021
Mitotech S.A. To Present at Biotech Showcase Digital 2021 Conference
October 23, 2020
Mitotech to present in Eyecelerator's Retina Livestream organized by AAO and ASCRS
August 25, 2020
December 12, 2019
October 29, 2018
October 23, 2018
July 19, 2018
Mitotech partners with Essex Bio-Technology for a late-stage clinical program in Dry Eye Disease
October 24, 2017
Mitotech announces new Dry Eye data set supporting SkQ1's novel mechanism of action
April 26, 2017
Mitotech's SkQ1 improved visual acuity in Leber's Hereditary Optic Neuropathy (LHON) patients
April 20, 2017
March 21, 2017
Mitotech's lead compound significantly increased lifespan of rapidly aging mice
February 10, 2017
Mitotech discusses SkQ1 and Dry Eye Disease in a recent Fierce Biotech article
February 7, 2017
Mitotech will attend the Biotech and Money conference in London, Feb 7-8, 2017
January 20, 2017
September 9, 2016
Mitotech S.A. is granted a patent in anti-aging
July 27, 2016
Mitotech S.A. announces its Ophthalmic Scientific Advisory Board
March 20, 2016
Oxidative stress and dry eye in Review of Ophthalmology
March 1, 2016
Mitotech S.A. to present at ARVO 2016
February 5, 2016
Mitotech CEO to present at the annual BIO CEO and Investor Conference 2016
January 25, 2016
Mitotech S.A. to initiate its first clinical study of a systemic formulation of SkQ1
January 10, 2016
December 27, 2015
October 16, 2015
Mitotech S.A. to present at the 2015 Sofinnova Japan Biopharma Partnering Conference
May 3, 2015
Mitotech's posters at ARVO 2015 in Denver, May 3-7
April 23, 2015
Mitotech Announces Phase 2 Data Showing Positive Effect of SkQ1 in Patients with Dry Eye Syndrome
April 21, 2014
May 14, 2013
Mitotech completes series of uveitis studies
December 9, 2012
Mitotech's posters at ARVO 2015 in Denver, May 3-7
January 17, 2012
Mitotech initiated pre-clinical program for SkQ1 compound in the U.S.